Dana-Farber Cancer Institute creates triple-negative breast cancer program

Boston-based Dana-Farber Cancer Institute has used a $5 million gift to establish the Benderson Family Program for Triple-Negative Breast Cancer.

Advertisement

The program focuses on advancing research into triple-negative breast cancer and enhancing the institute’s capabilities for treating the disease. The gift, given by the Benderson Family of Sarasota, Fla., will also be used to expand a comprehensive triple-negative breast cancer research registry and to support capital projects at Dana-Farber.

Eric P. Winer, MD, chief of the breast oncology division in the Susan F. Smith Center for Women’s Cancers at Dana-Farber, will serve as the program’s director.

More articles on oncology:
There are 568 genes that can trigger cancer, researchers say
7 things to know about oncologists’ personal finances
No. 1 for cancer care: What’s missing from rankings for this specialty?

At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.

Advertisement

Next Up in Oncology

Advertisement